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1. Introduction 
A fast-growing body of literature is providing evidence in favor of screening men for 
abdominal aortic aneurysm (AAA). Several large, randomized trials published in the past 
few years have consistently shown that screening reduces AAA-related mortality.18 
2. Cost-effectiveness of screening 
Longer-term mortality benefit and cost-effectiveness for abdominal aortic aneurysm (AAA) 
screening are uncertain.18 
In addition to the mortality benefit, evidence indicating that screening is highly cost-
effective is increasing.2, 34 In light of this evidence, national screening programs are now 
being considered in many countries.47, 46 
However, there is little evidence regarding long-term outcomes after AAA screening; almost 
all of the evidence from randomized trials is limited to the first 4 years after screening.18 
It is therefore expected that cost-effectiveness of screening will improve over time.18 
It is expected that the lifetime cost-effectiveness of screening will be highly favorable. 
Furthermore, these results show that the mortality benefit of an approximate 50% reduction 
in AAA-related death in patients invited to be screened is maintained at 7-year follow-up. 
The risk for AAA rupture remains low in patients with normal results on initial screening.18 
Patients with AAA detected in selective screening at the vascular laboratory had a high level 
of morbidity and inferior long-term survival when compared with the general population. 
Elective AAA repair rate was lower in this group than in patients with AAA detected in 
general screening programmes, with an acceptable perioperative mortality rate. Despite 
these factors, selective screening for AAA among patients referred to the vascular laboratory 
for suspected arterial disease was cost-effective under most assumptions with an estimated 
ICER at base-case of 11 084 Euro/LYG compared with non-screening.28 
Screening appears to reduce hospital AAA mortality and to be cost-effective.25 
The benefit of inviting men aged 65-74 to screening for abdominal aortic aneurysm 
continues at about the same rate 7-10 years after screening, as observed in previous years. 
The reduction in number of deaths related to abdominal aortic aneurysm in MASS is 
estimated as 42% at four years34, 47% at seven years18, and now 48% at 10 years. This is 
surprising as it might be expected that ruptures of the aneurysm in those originally screened 
as normal and incidental detection of abdominal aortic aneurysm in the control group 
would erode the benefit over time.45 
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A crucial problem is the extent to which those screened as normal will go on to develop an 
aneurysm that ruptures and whether rescreening of participants after a normal scan is 
justified at any stage.45 
Women are generally not considered a suitable target population for abdominal aortic 
aneurysm (AAA) screening. The main reason is not only the low prevalence of AAA but 
also a development of the disease later in life and an inferior relative long-term survival in 
women with AAA. However, other aspects of the disease, such as the higher rupture rate, 
indicate that AAA in women may be more severe than in men. Screening reduced the AAA 
rupture incidence by 33% and the AAA-related death rate by 35%. The cost per life year 
gained was estimated at $5911. The incremental cost-effectiveness ratio was similar to that 
found for screening men, which reflects the fact that the lower AAA prevalence in women is 
balanced by a higher rupture rate. Screening women for AAA may be cost-effective, and 
future evaluations on screening for AAA should include women.50 
Cost-effectiveness was rather insensitive to variations in prevalence >1%. Below this level, 
however, the cost per life year gained increased rapidly.50 
The rupture rate has a large impact on the cost-effectiveness of a screening program,10 and 
the higher rupture rate among women compensates for the lower prevalence and reduces 
the cost per life year saved by 64%.49 
The sensitivity analysis showed, however, that the incremental cost per life year gained was 
lower than what is generally considered cost-effective, even if the rupture rate among 
women with AAA was assumed to be the same as for men.50 
The life expectancy of the screened individuals is a key variable for the cost-effectiveness 
ratio.49 
The incremental cost per life year gained for screening all 65-year-old women for AAA was 
lower than what is generally considered cost-effectiveand was similar to that for screening 
men at the same age.This reflects the fact that in women, a low prevalence is balanced by a 
high rupture rate.50 
3. Treatment decisions  
The major problem with AAAs is the risk of rupture. AAA is often asymptomatic and if left 
undetected they will continue to expand and may eventually rupture.11 
Decisions about the treatment of AAAs are traditionally based upon the maximum cross-
sectional diameter. If the AAA diameter is 5.5 cm or larger then intervention is generally 
deemed appropriate.11 The diameter of an AAA is a well established objective criterion for 
selecting patients for treatment and when assessing the results following endovascular 
repair.11 
New treatments for abdominal aortic aneurysm may impact on a national screening 
programme and increase its effectiveness. Endovascular repair of aneurysms rather than 
conventional open repair is now used more widely for elective surgery but was used for 
only 9% of the elective procedures in MASS. In patients who are fit for open repair, and 
anatomically suitable for endovascular repair, endovascular repair has lower operative 
mortality than open repair and fewer deaths related to abdominal aortic aneurysm in the 
longer term10, 12, 13, 21; it may therefore be preferred by both patients and surgeons. Reliable 
evidence comparing endovascular repair of abdominal aortic aneurysms with open repair is 
currently available only up to four years of follow-up; it shows no difference in all cause 
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mortality21 but a substantial incidence of graft problems (for example, leaks around the graft 
or movement of the graft) and need for reinterventions after endovascular repair.13, 10 
The quality of life data collected in the trial around the time of screening showed no clear 
adverse or beneficial effects of screening or any long term effects after surgery.34, 29 
Patients with a detected AAA have yearly revisits to follow the expansion of the aneurysm. 
They are offered elective open surgery, if they are healthy enough, when the AAA has 
grown to >55 mm, has expanded rapidly, or has caused symptoms. Some patients with 
detected AAA fulfill the criteria for elective surgery at the time of screening and will be 
offered surgery as soon as possible.50 
4. Age and screening 
The prevalence also depends on the age of the screened population. However, the present 
lack of age-specific prevalence data in women makes a more precise analysis of the optimal 
screening age difficult.50 
The results suggest that aortic screening may be worthwhile extending to a wider age band. 
By focusing follow-up, this should give greater value for younger men in terms of 
community productivity and allows for selective intervention in the elderly.32 
The United States Preventative Services Task Force (USPSTF) recommends one-time 
screening for AAAs in men 65 to 75 years of age who have ever smoked and recommends 
against routine screening in women, and the Screening Abdominal Aortic Aneurysms Very 
Efficiently Act supports only a screening program for AAA in male ever- smokers when 
they turn 65 years old.5 
The mortality benefit of screening men aged 65-74 for abdominal aortic aneurysm is 
maintained up to 10 years and cost effectiveness becomes more favourable over time. To 
maximise the benefit from a screening programme, emphasis should be placed on achieving 
a high initial rate of attendance and good adherence to clinical follow-up, preventing delays 
in undertaking surgery, and maintaining a low operative mortality after elective surgery. 
On the basis of current evidence, rescreening of those originally screened as normal is not 
justified.45 
The reduced benefit of screening elderly males is due to the reduced life expectancy and to 
the demonstrated increased mortality after AAA repair.30 
5. Sex and
 
screening 
Among men, the rupture risk of an AAA was estimated at 0.8% per year among those with 
an AAA attending a screening and 1.9% among those with an AAA not attending a 
screening or not invited to a screening.49 Women were estimated to have a threefold higher 
rupture risk than men.37 Thus, the corresponding annual rupture risks were 2.4% and 5.7%, 
respectively, for women with AAA. Sixty-five percent of men with ruptured AAA die before 
surgery, and an additional 14% die during surgery, corresponding to an operative mortality 
of 40%.49The rate of surgery for ruptured AAA was lower for women50 and the operative 
mortality was higher. Thus, the total mortality for AAA rupture was estimated at 86.3% for 
women compared with 79% for men.50 
The Chichester screening trial is the only published evaluation of screening for AAA in 
women. Some 9342 women aged 65 to 80 years (mean age, 72 years) were randomized, with 
no difference in rupture rate between the screened and the control groups after 10 years 
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follow-up. The authors concluded that it was neither clinically indicated nor economically 
rational to screen women.40 However, a possible limitation that is likely to counteract the 
possible benefits of screening women is the biased mortality data based on official statistics. 
With a low autopsy rate, the reliability is limited in determining mortality rate from 
ruptured AAA. The autopsy rate has decreased to an overall 11% in Sweden, and is almost 
nonexistent among women >80 years old.1 
Among 2257 AAA patients enrolled in the UK Small Aneurysm Trial (UKSAT) or Small 
Aneurysm Study, the risk of rupture was, independently of age and initial AAA diameter, 
associated with female sex. The rupture rate was three times higher in women compared 
with men. 37 
Only one RCT, the Chichester trial, included women (n = 9342) aged 65–80 years old. In this 
trial, the prevalence of AAA >3 cm among women (1.3%) was substantially lower than in 
men (7.6%). The subgroup analysis addressing the effect of screening in women concluded 
that screening followed by surgery did not reduce mortality.41 
In women, the incidence of ruptured AAA was similar in the control and screening groups, 
and in general the incidence of death from ruptured aneurysm increased with age, since 
more than 70% of ruptures occurred among women > 80 years.41 
On the basis of the low prevalence of AAA in women and the unfavorable RR, screening of 
women may not be beneficial or cost effective.41 
The evidence available from the Chichester trial regarding the effect of population screening 
in women should be considered with caution because of the possibility of confounding 
factors or biases. The gender analysis was a subgroup analysis and, as expected, the number 
of participating women was considerably lower than men. Since the risk factors associated 
with increased risk for surgery are the same as those associated with increased incidence of 
AAAs, it is possible that many women were excluded, giving a falsely lower incidence of 
AAAs (ascertainment bias).5 
Before making a final decision on the effectiveness of AAA screening in women, a number 
of features unique to women should be considered. The lower prevalence of AAA in women 
is most likely due to their lower burden of risk factors compared with men. The evidence 
supports that like in men, for women the probability of AAAs is increased among smokers 
(odds ratio (OR) 3.8), those aged >70 years (OR 1.8), family history (OR 2.6), and pre-existing 
cerebrovascular disease (OR 3.20).20 
Like coronary heart disease, the increase in prevalence of AAA among women appears to 
occur approximately one decade after men. Because of this 10-year delay in onset, and lower 
burden of AAAs likely due to the currently more favorable cardiovascular risk factor profile 
of women, the cost effectiveness of screening and repair of AAA to prevent death does not 
favor screening at present.5 
However, we must also consider the observation that although women have a lower 
incidence of AAA, when they are found to have an AAA > 3 cm the risk of rupture is greater 
than that of men, 33, 6 and mortality associated with surgery for ruptured aortic aneurysms is 
higher compared with that in men.41 
This higher risk of rupture in women may be because the prevalence of the disease was 
defined as an aorta with a diameter >3 cm, which is the usual threshold used for men, and it 
does not take into account the smaller size of a normal aorta in women. Thus, an aneurysm 
of 5 cm in a woman may have a higher rupture rate because it is equivalent to an aneurysm 
of 6 cm in a man. Given the state of the evidence, a number of outstanding issues should be 
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considered for the screening of AAA in women. First, the evidence does not support 
population-based screening over 65 years of age, due to the low incidence of AAA. 
However, it would be reasonable to recommend targeted screening of ͂higher risk 
women̓, including those of an older age, who are current or had a long history of 
smoking, as well as those with co-existing vascular disease.5 
In men, an AAA diameter of 55 mm generally justifies elective repair, whereas it has been 
suggested that women may benefit from a lower threshold for surgery. A lower threshold 
diameter for surgical repair in women (≤50 mm) may reduce the difference in surgery rate 
and the likelihood of an AAA to rupture. In the UKSAT, the mean AAA diameter at rupture 
was 50 mm for women and 60 mm for men. They concluded that different thresholds should 
apply to women than men when AAA repair is being considered.37 In the Chichester trial, 
however, a threshold diameter of 60 mm did not result in higher rupture rate.40 
The relative long-term survival after surgery for AAA was found to be better in men than in 
women, although the crude long-term survival was similar between men and women, 
because women in general have a longer life expectancy. The assumed additional relative 
mortality in women with AAA compared with men increased the cost per life years saved 
by 30%.50 
the decrease in AAA-specific mortality among women invited to screening was only 32% 
compared with 50% among men. The explanation lies in the complex relations between 
mortality, risk of rupture, and risk of elective surgery. If women had an identical 
compliance and rupture rate as men, the model would generate a decrease in AAA-specific 
mortality of 43%.50 
6. Size of aneurysm 
Within group of detected aneurysms, surveillance involved rescanning: annually for those 
with diameters of 3.0-4.4 cm and every three months for those of 4.5-5.4 cm. Patients were 
referred to a hospital outpatient clinic for possible elective surgery when the aneurysm 
reached 5.5 cm, the aneurysm had expanded by 1.0 cm or more in one year, or symptoms 
attributable to the aneurysm were reported.45 
The prevalence of the disease is, however, highly dependent on the definition used.26 In 
most population-based screening studies including women, an AAA was defined as the 
maximum infrarenal aortic diameter being ≥30 mm, as proposed by McGregor.31 Because 
the normal aortic diameter differs by gender,44 a fixed diameter may not be an optimal 
definition of AAA and may partly explain the differences seen in prevalence between men 
and women. 
In the Chichester trial, four of the 10 women from the screened group who had AAA 
rupture or emergency repair  initially had a normal scan.40 This may be the result of how an 
AAA was defined, where a fixed diameter may result in false-negative findings, or a 
consequence of the natural history of AAA development among women. 
7. Rescreening 
Two of the RCTs looked at the need for rescreening in individuals with <3 cm AAA: the 
Viborg trial repeated an ultrasound examination (USE) 3 to 5 years after the first one and 
found that new AAA > 3 cm occurred in 28% (95% CI 21-35), but none were clinically 
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significant (the largest <48 mm); and the Chichester trial rescreened patients with aortic 
diameter <3 cm every 2 years and identified 4.1% AAA, which were all <3.8 cm in 
diameter.30  
Recommending rescreening those with an initial normal scan would only become justified 
in subsequent years if future analyses show that there is a further noticeable increase in 
ruptures in this group that is not sufficiently offset by the reduction in number of deaths 
related to abdominal aortic aneurysm for those with an aneurysm detected (or rendered 
unimportant by the overall toll of mortality from all causes).45 
8. Psychological effects of screening 
The offer of screening causes transient psychological stress in subjects found not to have 
AAA. However, diagnosis of an AAA seems to impair QL permanently and progressively in 
conservatively treated cases. This impairment seems reversible by operation. Nevertheless, 
the impairment seems considerable, and must be considered in the management of AAA 
and in the final evaluation of screening for AAA. 26 
Several concerns have been raised about the utility of population-based screening for AAA. 
It has been proposed that patients who are found to have “small” aneurysms will experience 
a diminished quality of life related to concern about rupture.17 
For strategies toward other target groups, and management of small AAAs, prediction 
models and cost-effectiveness analyses are needed to provide guidance.14 
9. Family history  and screening 
The ADAM study found that a family history positive for presence of AAA is associated 
with a two-fold increase in the risk of having an AAA with no difference between men and 
women.30 
Familial AAA do not expand faster nor are they associated with unusual locations, but they 
may occur earlier in life. Screening causes psychological side effects, and it could therefore 
be offered to male first-degree relatives from the age of 60, and be confined to 
ultrasonographic scanning of the infrarenal abdominal aorta at five-year intervals. 23 
Aging brothers of patients with known abdominal aortic aneurysm have the highest risk for 
developing the disease; the prevalence of the disease in siblings older than 60 years of age is 
18%.39 
Ultrasonographic screening is recommended in brothers (50 years) of patients with 
aneurysms of the abdominal aorta.4 
10. Screening methods 
10.1 Physical examination 
A focused physical examination has been investigated as a screening tool to identify AAA. 
Sensitivity has been reported in the range of 76% to 85% and specificity 85% for AAA >5 cm 
with moderate interobserver agreement (kappa = 0.5).31 The diagnostic properties of 
physical examination require further investigation.30 
10.2 Ultrasonography 
Ultrasonography is the detection method of choice for AAA screening: it is cheap and 
noninvasive and can be used easily in a community setting.36 
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Results from a large, pragmatic randomized trial show that the early mortality benefit of 
screening ultrasonography for AAA is maintained in the longer term and that the cost-
effectiveness of screening improves over time.18 
Ultrasound screening to identify abdominal aortic aneurysms (AAA) >5cm followed by 
surgery reduces cause-specific mortality among individuals older than 65 years. This benefit 
is not apparent among men older than 75 years, 5 and there is some controversy regarding 
the benefit of screening for AAA among women.5 
The United Kingdom Multicentre Aneurysm Screening Study (MASS) 18,46 has provided most 
of the worldwide randomised evidence for the mortality benefit after ultrasound screening 
for abdominal aortic aneurysm.8, 16 The UK screening programme for men aged 65 is based 
closely on the protocol and procedures in MASS. Some uncertainties relating to screening 
remain, however, including its long term benefit in terms of mortality and cost effectiveness, 
whether rescreening those with a previously normal scan is warranted, and the extent to 
which incidental detection of abdominal aortic aneurysm erodes the benefit of a systematic 
screening policy over time. It might be expected that the mortality benefit seen in the early 
years after one-off screening would decrease over time. MASS, started in 1997, runs more 
than 10 years ahead of the UK national screening programme and is uniquely positioned to 
tackle these uncertainties and to inform the development of the national programme.45 
The neck of the aneurysm and suprarenal aorta might be more difficult to visualize with 
ultrasonography, and most ultrasound screening studies report only the maximum anterior-
posterior diameter. However, ultrasonography also can provide information about the size 
and shape of the luminal thrombus in an AAA and the presence of iliac aneurysms.36 
It is able to define the diameter of the infrarenal aorta in 98% (95% CI 92-94) of individuals, 
with a sensitivity and specificity of 100% and 98%, respectively. The correlation between 
observers for ultrasound measurements of the abdominal aorta is high (Spearman 
coefficient = 0.99), but abdominal girth reduces the precision of the measurement.30 
Abdominal palpation has only moderate overall sensitivity for detecting AAA, but appears 
to be highly sensitive for diagnosis of AAAs large enough to warrant elective intervention in 
patients who do not have a large girth. Abdominal palpation has good sensitivity even in 
patients with a large girth if the aorta is palpable.15 
Many large AAAs currently remain undetected until rupture, and many small AAAs that 
will never rupture are detected incidentally and repaired, with some resulting morbidity 
and mortality. Both scenarios contribute to aortic aneurysms remaining a leading cause of 
death. Recent randomized trials have demonstrated a substantial reduction in AAA-related 
mortality from ultrasonographic screening and resulting elective repair. If the U.S. 
Preventive Services Task Force recommends AAA screening, health plans, including 
Medicare, will probably follow with coverage and the era of AAA screening will begin. 
Meanwhile, it is reasonable to offer 1-time ultrasonographic screening to men 65 to 79 years 
of age who have ever smoked, especially if elective repair can be reserved for AAAs 5.5 cm 
or larger. If screening is accompanied by prudent use of elective repair, the mortality 
associated with AAA may at last be reduced. 19 
10.3 Computed tomography (CT) scan 
The accuracy of radiographers in performing AAA CT measurements is encouraging. 
Variability exists for both professions, and in some instances may be clinically significant. 
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Observers should be aware of measurement variability issues and have an understanding of 
the factors responsible. Careful and repeat measurements of AAAs around 5.5 cm are 
recommended in order to define treatment.11 
A good level of agreement exists between radiologists and radiographers in performing CT 
measurements of maximum AAA diameter. Variability for both professions does exist and 
can be significant in certain situations, observers should be aware of the existence of 
variability especially when making treatment decisions. It is technically feasible for 
radiographers to perform such measurements, whether this area of role extension should be 
explored needs further investigation. Understanding the factors which play a role in 
observer variability is paramount; variability may be decreased if using standardised 
measurement protocols, 3D techniques and computer-assisted measurements. If the latter is 
to be accepted then these measurements will require validation and clinical checking before 
prescribing treatment.11 
10.4 Magnetic Resonance Images (MRI) 
It seems that MRI screening of older men with LBP for AAA, especially in smokers or 
patients with a recent history of smoking, is advantageous. Further studies are needed to 
determine the best modality and the most feasible method of screening.42 
10.5 Plasma levels of plasmin-antiplasmin-complexes 
Three proteolytic systems seem involved in the aneurysmal degradation of the aortic wall. 
Plasmin is a common activator of the systems and could thus be predictive for the 
progression of abdominal aortic aneurysms (AAAs).24 
The levels of elastase have been found elevated in the circulation and aneurysmal walls 
compared with those with aortic occlusive atherosclerosis.3, 7, 9Furthermore, circulating 
levels of Cystatin C B, the major inhibitor of cysteine proteases, have been reported 
decreased in aneurysmal cases compared with a sex-matched and age-matched control 
group.43 Finally, the levels of various metallodependent proteases (MMPs), especially 
MMP2 and MMP9, have been found elevated in aneurysmal aortic walls compared with 
aortic walls of occlusive atherosclerosis35, 38, and we have earlier reported a positive 
significant correlation between the plasma level of MMP9 and the expansion of small 
AAAs.27The progression of AAA is correlated with the PAP level, which seems to have a 
predictive value similar to the best serologic predictor known, serum-elastin-peptides.24 
10.6 Genetic screening 
Nine functional positional candidate genes on AAA1 locus on chromosome 19 were 
investigated. Two of the genes, CD22 and PEPD showed modest level of evidence of being 
involved in AAA pathogenesis. This evidence came from a nominal association of SNPs 
residing in these genes to AAA, identification of novel sequence changes and expression of 
these proteins in aneurysmal tissue. If replicated in independent studies, the findings 
provide important information about AAA pathogenesis. Association testing of the 
functional positional candidate genes on the AAA1 locus on chromosome 19q13 
demonstrated nominal association in three genes. PEPD and CD22 were considered the 
most promising candidate genes for altering AAA risk, based on gene function, association 
evidence, gene expression, and protein expression. 22 
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